Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow’s Milk Protein Allergy (CMPA)

by | Mar 19, 2026 | Clinical Trials | 0 comments

​ Conditions: Cow’s Milk Protein Allergy (CMPA)

Interventions: Other: Feihe Extensively Hydrolyzed Formula; Other: Nestlé Extensively Hydrolyzed Formula

Sponsors: Heilongjiang Feihe Dairy Co. Ltd.

Not yet recruiting Conditions: Cow’s Milk Protein Allergy (CMPA)
Interventions: Other: Feihe Extensively Hydrolyzed Formula; Other: Nestlé Extensively Hydrolyzed Formula
Sponsors: Heilongjiang Feihe Dairy Co. Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *